TransHeps AG provides specialized laboratory and advisory services for the assessment of drug‑induced liver injury (DILI), including the patient‑specific MetaHeps assay for DILI causality testing. The company also performs mechanistic in‑vitro studies (such as transporter and mitochondrial assays) and offers expert consulting on trial design, sample logistics, data analysis and reporting for pharma, biotech and CRO clients.
AI-generated
Offering
Products & services
Industry:Research & Development
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
iDILI causality assays for clinical studies and pharmacovigilance, including application, logistics, study design, sample preparation, shipment, data analysis, data interpretation and reporting.
Expert Advisory Services/Consulting
Expert advisory services/consulting for DILI: analysis of clinical DILI signals, hypothesis generation, experimental study design, evaluation, reporting and advice by experienced scientists.
Mechanistic Investigations
Mechanistic investigations for DILI: transporter inhibition in monolayer, vesicle and transwell assays, as well as studies of mitochondrial dysfunction.
Knowledge
No knowledge articles yet
Once TransHeps AG has claimed this profile, we'll publish editorial articles and case studies here together.